Eric Kimelblatt

Head of Market Access at Stallergenes Greer

Speaker

Eric has 25+ years of experience in pharma, focused on Market Access, Trade/Distribution, Patient Services, and Government Compliance.

Half of that time he has worked at drug manufacturers: Stallergenes Greer, Gilead, Cephalon.

The other half was spent consulting for drug manufacturers while working at: Viking, Artia, IMS/IQVIA, Envision, I-many, SAP.

Eric has been involved in the strategy, planning, and execution of 80+ new drug launches, across nearly every TA, including pharmacy/medical benefit drugs, cures for HepC, orphan/rare/ultra-rare disease drugs, and cell/gene therapies.

He is a graduate of the Wharton Business School at University of Pennsylvania, and resides in West Chester, PA with his wife and dogs.